New hope for FSGS: experimental drug APL2 enters Late-Stage trial
Disease control
Not yet recruiting
This study tests a drug called APL2 for people with a kidney disease called FSGS, which causes protein leakage in urine and can lead to kidney failure. The trial has two parts: first, adults receive APL2 to see if it works; then, adults and teens are randomly assigned to get APL2…
Phase: PHASE2, PHASE3 • Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 07, 2026 18:42 UTC